Racial Disparities Seen for Cost of Unplanned Care After Breast Reconstruction
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
WEDNESDAY, Aug. 2, 2023 -- While race is not a significant predictor of unplanned hospital visits after breast reconstruction surgery, racial minorities bear a higher cost burden than White breast reconstruction patients, according to a study published online in the August issue of Plastic and Reconstructive Surgery.
Jacob S. Nasser, from George Washington University in Washington, D.C., and colleagues examined the effect of race on the rate and cost of unplanned hospitalizations after breast reconstruction procedures. The analysis included 17,042 patients.
The researchers found that the overall rate of an unplanned visit was 5 percent. While the rates of readmissions were higher among Black patients (6 percent) and Hispanic patients (7 percent) versus White patients (5 percent), race was not an independent predictor of an unplanned visit when controlling for patient-level characteristics. However, expenditure was significantly higher for Black patients (adjusted cost ratio, 1.35) and Hispanic patients (adjusted cost ratio, 1.34) versus White patients.
"Adjusted payment models may be a strategy to reduce disparities in surgical care," the authors write. "In addition, direct and indirect measures of disparities should be used when examining health care disparities to identify consequences of inequities more robustly."
One author reported receiving book royalties from Wolters Kluwer and Elsevier.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Read this next
Resistance Exercise Boosts Outcomes After Early-Stage Breast Cancer Surgery
FRIDAY, June 7, 2024 -- Early resistance exercise following surgery for early-stage breast cancer improves shoulder range of motion (ROM) and strength at one month and six months...
ASCO: Neoadjuvant Ipilimumab + Nivolumab Ups Survival in Resectable Melanoma
WEDNESDAY, June 5, 2024 -- Neoadjuvant ipilimumab plus nivolumab followed by surgery results in longer event-free survival than surgery followed by adjuvant nivolumab among...
Odds of Death Lower With Surgery for Hip Fracture in Patients With Dementia
MONDAY, June 3, 2024 -- For community-dwelling patients with dementia and fracture of the femoral head and neck, the odds of death are lower for those treated surgically...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.